Latigo Biotherapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LTGO | LKFT | BHVN | LRMR | LBRX | LXRX | |
|---|---|---|---|---|---|---|
| Market cap | 930.84M | 2.25B | 2.30B | 286.72M | 1.32B | 658.53M |
| P/E (TTM) | — | 3.2 | — | — | 408.5 | — |
| Forward P/E | -6.7 | -28.6 | -8.2 | -2.6 | -7.6 | -7.8 |
| Price/book | -0.1 | 12.2 | -23.4 | 2.3 | 3.5 | 3.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −23.07% | +9.26% | +78.66% | −20.46% | +163.38% | +3.50% |
| Today | −3.64% | +6.03% | −2.37% | +8.66% | +1.29% | +1.37% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LTGO news ›Latigo Biotherapeutics, Inc. (LTGO) - What Are Investment Firms Thinking About This Stock?
Read Our Latest Research Report on LTGO Shares of NASDAQ LTGO opened at $14.57 on Wednesday. The business has a 50 day moving average price of $18.59. The company has a market capitalization of $965.99 million and a P/E ratio of -0.28.…
Latigo Biotherapeutics (NASDAQ:LTGO) Sets New 12-Month Low - Should You Sell?
Shares of Latigo Biotherapeutics, Inc. (NASDAQ:LTGO - Get Free Report) hit a new 52-week low during mid-day trading on Monday. The stock traded as low as $13.26 and last traded at $13.51, with a volume of 289,064 shares traded. The stock…
More from 1 other outlet
Largo (TSE:LGO) Stock Price Up 4.9% – Here’s What Happened
Posted by Michael Walen on Oct 17th, 2026 Largo Inc. (TSE:LGO – Get Free Report)’s share price traded up 4.9% during trading on Friday. The stock traded as high as C$0.66 and last traded at C$0.64. Approximately 103,010 shares traded hands…
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy
Shares of Larimar Therapeutics Inc. (LRMR) surged over 60% on Wednesday to their strongest session on record before pricing an upsized $100 million stock offering, extending gains following the FDA’s Breakthrough Therapy designation for…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com3
- themarketsdaily.com2
- defenseworld.net1
- stocktwits.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.